Yesterday
On The Fly
Get caught up quickly on…
Show Hide Related Items >> <<
03/17/23 XPeng rises 10.8% 03/17/23 XPeng announces 5,218 vehicles delivered in January 03/10/23 XPeng laiuches P7i sports sedan in China 03/01/23 XPeng delivers 6,010 Smart EVs in February 03/20/23 S&P revises UBS Group outlook to Negative, affirms ratings 03/20/23 UBS rises 7.9% 03/19/23 Fly Intel: Top five weekend stock stories 03/19/23 Credit Suisse says UBS confident staff employment will be continued 03/22/23 Stratasys up 4.5% at $15.25 as its board rejects Nano Dimension offer 03/13/23 Nano Dimension CEO provides rationale for acquisition of Stratasys 03/24/23 Block continues selloff, shares down 4% to $59.31 03/23/23 Cathie Wood's ARK Investment bought 338K shares of Block today 03/23/23 Block exploring legal action against Hindenburg after 'misleading' report 03/23/23 Block calls Hindenburg report 'factually inaccurate and misleading' 03/23/23 Stifel Financial announces significant expansion of venture banking business 03/22/23 Senators Scott, Warren unveil bipartisan Fed oversight legislation 03/22/23 Stronghold Digital reports no direct exposure to SVB, Signature, Silvergate 03/20/23 WhiteHorse Finance says no exposure to Silicon Valley Bank or Signature Bank 03/24/23 Stifel Financial co-president Zemlyak buys 20,000 common shares 03/01/23 Stifel Financial closes acquisition of Torreya partners 02/16/23 Stifel Financial announces launch of an ASPG, new hires 03/23/23 Scholastic falls 11% to $36.90 after lowering FY23 guidance 03/23/23 Scholastic board authorizes additional $50M for share repurchases 02/22/23 Scholastic announces strategic partnership with SoapBox Labs 12/15/22 Scholastic raises share repurchase authorization to $75M 02/13/23 ReNew Energy to rebrand as ReNew 12/16/22 ReNew Energy Global signs 150 MW agreement with Microsoft $820.34 / +17.72 (+2.21%)
03/23/23 Regeneron, Sanofi report Dupixent trial meets primary and secondary endpoints 03/22/23 Regeneron announces FDA approval of Evkeeza for young children 03/21/23 Regeneron, Sanofi announce EC approval of Dupixent 03/19/23 Regeneron, Sanofi present results from Dupixent clinical trial 03/24/23 Pharming up 22% after resuming trading following announcement of FDA approval 03/24/23 Pharming up 7% after FDA approves Joenja for APDS 03/24/23 Pharming announces FDA approval of Joenja 02/21/23 Pharming announces first patient enrolled in leniolisib trial 03/24/23 Oncorus expects cash to fund expenditures into early 2024 03/10/23 Oncorus informs investors of holdings with SVB Financial 01/04/23 Oncorus announces research collaboration with Daewoong Pharmaceutical 11/30/22 Oncorus announces reprioritization of lead product candidate ONCR-021 03/23/23 Nano Dimension to review options relative to Stratasys and alternative targets 03/23/23 Nano Dimension releases video on products, materials, technologies 03/22/23 Stratasys board unanimously rejects acquisition proposal from Nano Dimension 03/21/23 Nano Dimension responds to Murchinson claims about shareholder meeting results 03/22/23 Microsoft, CarbonCapture reach carbon removal credits agreement 03/22/23 Syneos Health and KX team on predictive analytics, AI and ML 03/21/23 Nvidia says Nvidia Omniverse Cloud now available to select enterprises 03/06/23 Altria Group to acquire NJOY Holdings for $2.75B in cash 03/03/23 Altria Group exchanges minority stake in JUUL Labs for heated tobacco IP rights 01/24/23 Altria Group trading resumes 01/24/23 Altria Group trading halted, volatility trading pause $205.99 / +1.695 (+0.83%)
03/21/23 Nvidia announces availability of new products featuring H100 Tensor Core GPU 03/15/23 Facebook Ireland violated law over data use, Amsterdam court ruled 03/15/23 Oportun Financial expands executive team with key new hires 03/14/23 Meta targeting summer to complete analysis from hybrid work year of learning 03/16/23 Leap Therapeutics provides update on BeiGene option agreement for DKN-01 01/17/23 Leap Therapeutics acquires Flame Biosciences 11/07/22 Leap Therapeutics' DKN-01 demonstrates preclinical tumor regression in study 10/17/22 Leap Therapeutics enrolls first patient in study of colorectal cancer candidate 03/22/23 JPMorgan to acquire Aumni, terms not disclosed 03/21/23 Campbell Lutyens and J.P. Morgan announce collaboration in 2NDRY advisory market 03/16/23 First Republic confirms it will receive deposits totaling $30B from banks 03/13/23 Joann announces $100M FILO credit facility 10/10/22 Joann, Sutton Foster team up for World Mental Health Day IMPL Impel Pharmaceuticals 03/24/23 Impel Pharmaceuticals sees Trudhesa delivering 80K-110K TRx for 2023 03/24/23 Impel Pharmaceuticals expects cash to fund operations into 3Q23 02/22/23 Impel Pharmaceuticals announces strategic reprioritization, departure of CMO 09/28/22 Impel Pharmaceuticals Inc trading resumes 03/24/23 Humacyte expects cash to fund operations through 2024 01/24/23 Humacyte announces publication of 6-year outcomes in Phase 2 study of HAV 12/13/22 Humacyte hosts KOL webinar on vascular trauma 11/10/22 Humacyte expects cash to fund operations through 2024 03/24/23 Farfetch falls -8.1% 02/24/23 Farfetch rises 13.0% 02/23/23 Farfetch CFO Jordan to step down by end of 2023 01/18/23 Farfetch announces changes to leadership team 03/24/23 Deutsche Bank falls -6.7% 03/24/23 Deutsche Bank falls -6.5% 03/22/23 Deutsche Bank raises prime lending rate to 8.00% from 7.75%, effective March 23 02/02/23 Deutsche Bank reaffirms financial targets for 2025 03/23/23 Cathie Wood's ARK Investment bought 269K shares of Coinbase today 03/22/23 Coinbase says 'we are confident in the legality of our assets and services' 03/22/23 Coinbase falls 7% to $71.70 after announcing Wells Notice from SEC 03/22/23 Coinbase receives Wells Notice from SEC 02/03/23 Clorox rises 9.6% 02/02/23 Clorox sees FX headwinds a 2-point reduction to FY23 sales 02/02/23 Clorox CEO says 'actions we are taking to rebuild margin are working' 02/02/23 Clorox reports Q2 gross margin up 320 bps to 36.2% from 33% a year ago 03/16/23 Fed, Treasury say banks' deposits in First Republic show system's 'resilience' 03/16/23 Group of banks confirm plan to make deposits totaling $30B in First Republic 03/24/23 CMA 'narrows scope of concerns' in Microsoft-Activision review 03/15/23 Microsoft signs 10-year Xbox PC game partnership with Ubitus 03/14/23 Blizzard's Ferguson says 'no plans' for 'Diablo IV' on Game Pass 03/10/23 Sony says 'Hogwarts Legacy' most downloaded PS5 game in February AMPX Amprius Technologies 03/24/23 Amprius Technologies falls -8.0% 03/24/23 Amprius Technologies rises 6.8% 03/23/23 Amprius Technologies says will be 'limited by manufacturing capacity' 03/06/23 Amprius Technologies selects Colorado for new facility 03/02/23 Yield10 Bioscience, American Airlines sign MOU to form collaboration 02/23/23 American Airlines chairman Doug Parker to retire, Greg Smith to succeed 02/08/23 American Airlines announces proposed offering of senior secured notes 01/26/23 American Airlines sees delivery of 17 737 Max 8s in 2023 02/10/23 BofA Deutsche Bank downgraded to Underperform from Neutral at BofA 02/08/23 UBS Deutsche Bank price target raised to EUR 18.80 from EUR 16.30 at UBS 02/03/23 Credit Suisse Deutsche Bank price target raised to EUR 11 from EUR 10.50 at Credit Suisse 01/13/23 Barclays Deutsche Bank price target raised to EUR 12.50 from EUR 11.50 at Barclays 11/10/22 UBS UBS downgrades Altria to Sell on consumer trade down risk 11/10/22 UBS Altria Group downgraded to Sell from Neutral at UBS 11/02/22 Morgan Stanley Philip Morris price target raised to $109 from $102 at Morgan Stanley 10/28/22 Stifel Altria JV news trumps 'rare' EPS miss, says Stifel 03/20/23 Deutsche Bank Clorox price target lowered to $147 from $152 at Deutsche Bank 02/16/23 Citi Citi launches beverage, personal space with six buys, two sells 02/16/23 Citi Clorox initiated with a Neutral at Citi 02/06/23 Barclays Clorox price target lowered to $108 from $110 at Barclays 03/24/23 Loop Capital Joann price target lowered to $2 from $4 at Loop Capital 12/14/22 Barclays Joann price target lowered to $3 from $5 at Barclays 12/13/22 Loop Capital Joann price target lowered to $4 from $7 at Loop Capital 09/02/22 Wells Fargo Joann price target lowered to $4 from $5 at Wells Fargo 03/24/23 Compass Point Coinbase Wells notice fight will take 'years to resolve,' says Compass Point 03/24/23 TD Cowen Coinbase downgraded to Underperform from Market Perform at TD Cowen 03/23/23 BofA SEC action to weigh on Coinbase shares, says BofA 03/23/23 Jefferies Coinbase Wells notice likely precursor to enforcement action, says Jefferies 03/24/23 Oppenheimer Oppenheimer remains on the sidelines for Block after short report 03/24/23 BofA Block shares 'overreacting' to short seller report, says BofA 03/24/23 Citi Block short seller response likely not enough, says Citi 03/24/23 Atlantic Equities Atlantic Equities downgrades Block pending more clarity on short report 03/24/23 Bernstein XPeng downgraded to Market Perform from Outperform at Bernstein 03/24/23 Bernstein XPeng downgraded to Market Perform from Outperform at Bernstein 03/20/23 Morgan Stanley XPeng price target raised to $12.50 from $12 at Morgan Stanley 03/20/23 Morgan Stanley Li Auto price target raised to $30 from $23 at Morgan Stanley $820.34 / +17.72 (+2.21%)
03/24/23 BMO Capital Regeneron price target raised to $1,040 from $1,025 at BMO Capital 03/24/23 Wells Fargo Regeneron price target raised to $915 from $860 at Wells Fargo 03/24/23 Baird Regeneron price target raised to $800 from $756 at Baird 03/24/23 Barclays Regeneron price target raised to $915 from $815 at Barclays 03/24/23 Jefferies UBS downgraded to Hold from Buy at Jefferies 03/20/23 Barclays European Banks sector view downgraded to Neutral at Barclays 03/20/23 Societe Generale UBS downgraded to Hold from Buy at Societe Generale 03/20/23 Keefe Bruyette UBS downgraded to Underperform from Market Perform at Keefe Bruyette 03/24/23 RBC Capital JPMorgan price target lowered to $132 from $150 at RBC Capital 03/13/23 Wells Fargo Wells Fargo upgrades JPMorgan on 'Goliath is Winning' theme 03/13/23 Wells Fargo JPMorgan upgraded to Overweight from Equal Weight at Wells Fargo 02/24/23 Morgan Stanley JPMorgan price target raised to $173 from $167 at Morgan Stanley 03/24/23 Morgan Stanley nCino price target lowered to $27 from $35 at Morgan Stanley 03/23/23 Raymond James Block short report doesn't include 'bombshell,' says Raymond James 03/22/23 BofA Regional bank distress gives CME Group a new growth opportunity, says BofA 03/20/23 Benchmark Aspen Aerogels upgraded to Buy from Hold at Benchmark $205.99 / +1.695 (+0.83%)
03/24/23 JPMorgan Meta Platforms price target raised to $270 from $225 at JPMorgan 03/24/23 Barclays Meta Platforms price target raised to $270 from $260 at Barclays 03/22/23 KeyBanc Meta Platforms upgraded to Overweight from Sector Weight at KeyBanc 03/21/23 Morgan Stanley Meta Platforms upgraded to Overweight from Equal Weight at Morgan Stanley 03/17/23 Wolfe Research American Airlines upgraded to Peer Perform from Underperform at Wolfe Research 03/17/23 Wolfe Research American Airlines upgraded to Peer Perform from Underperform at Wolfe Research 03/10/23 Barclays American Airlines price target raised to $15 from $14 at Barclays 03/07/23 Evercore ISI Delta Air Lines upgraded to Outperform from In Line at Evercore ISI 03/24/23 RBC Capital Bank of America price target lowered to $34 from $40 at RBC Capital 03/08/23 Odeon Capital Bank of America downgraded to Hold from Buy at Odeon Capital 02/08/23 Keefe Bruyette Keefe Bruyette downgrades 'vulnerable' Bank of America to Underperform 02/08/23 Keefe Bruyette Bank of America downgraded to Underperform at Keefe Bruyette 03/10/23 Lake Street Nano Dimension made 'lowball offer' Stratasys won't accept, says Lake Street 03/03/23 Lake Street Stratasys price target raised to $22 from $20 at Lake Street 01/04/23 Needham Needham upgrades Stratasys to Buy, sees valuation reflect more challenging 2023 01/04/23 Needham Stratasys upgraded to Buy from Hold at Needham 03/21/23 Morgan Stanley Microsoft app store longer-term Apple risk 'worth watching,' says Morgan Stanley 02/16/23 Deutsche Bank Deutsche upgrades Activision to Buy, says best risk/reward in gaming 02/16/23 Deutsche Bank Activision Blizzard upgraded to Buy from Hold at Deutsche Bank 02/10/23 Roth MKM Activision Blizzard price target lowered to $88 from $95 at Roth MKM 03/20/23 Stifel Alphabet resumed with a Buy at Stifel 03/20/23 Evercore ISI Microsoft price target raised to $295 from $280 at Evercore ISI 03/17/23 Mizuho Microsoft price target raised to $315 from $300 at Mizuho AMPX Amprius Technologies 12/02/22 B. Riley B. Riley starts 'early battery winner' Amprius with Buy, $14 target 12/01/22 B. Riley Amprius Technologies initiated with a Buy at B. Riley 10/27/22 EF Hutton Amprius Technologies initiated with a Buy at EF Hutton 10/13/22 Oppenheimer Amprius Technologies initiated with an Outperform at Oppenheimer 03/24/23 Citi Farfetch price target lowered to $4 from $6 at Citi 03/24/23 JMP Securities Farfetch initiated with a Market Perform at JMP Securities 01/30/23 KeyBanc KeyBanc keeps Overweight on Farfetch, lowers price target to $11 12/15/22 Oppenheimer Farfetch price target lowered to $7 from $14 at Oppenheimer IMPL Impel Pharmaceuticals 11/15/22 Wedbush Wedbush downgrades Impel Pharmaceuticals to Neutral, lowers price target to $5 11/15/22 Wedbush Impel Pharmaceuticals downgraded to Neutral from Outperform at Wedbush 08/24/22 JonesResearch Impel Pharmaceuticals initiated with a Buy at JonesTrading 01/12/23 Citi Stifel Financial price target raised to $65 from $60 at Citi 01/10/23 JMP Securities Stifel Financial price target lowered to $95 from $98 at JMP Securities 11/22/22 UBS Stifel Financial initiated with a Neutral at UBS 10/12/22 Citi Citi starts exchanges and brokers with CME, MarketAxess among top picks 12/06/22 H.C. Wainwright Oncorus downgraded to Neutral from Buy at H.C. Wainwright 11/30/22 Chardan Oncorus downgraded to Neutral from Buy at Chardan 11/30/22 Piper Sandler Piper downgrades Oncorus with plug pulled on lead program 11/30/22 Piper Sandler Oncorus downgraded to Neutral from Overweight at Piper Sandler 03/17/23 Piper Sandler Leap Therapeutics news 'disappointing at first glance,' says Piper Sandler 03/17/23 Mizuho Leap Therapeutics price target lowered to $2 from $3 at Mizuho 01/27/23 Mizuho Leap Therapeutics price target lowered to $3 from $6 at Mizuho 01/17/23 Piper Sandler Leap Therapeutics price target lowered to $3 from $4 at Piper Sandler 03/12/23 BTIG BTIG finds medical technology stocks with exposure with SVB 12/19/22 TD Cowen Humacyte price target lowered to $5 from $8 at Cowen 11/10/22 Piper Sandler Humacyte price target lowered to $2.75 from $3.50 at Piper Sandler 10/12/22 Piper Sandler CMS proposal a positive for Med Tech sector, says Piper Sandler 03/17/23 XPeng sees Q1 revenue down 43.7%-46.3%, consensus $882.99M 03/17/23 XPeng reports Q4 adjusted EPS (37c), consensus (36c) 11/30/22 XPeng sees Q4 revenue RMB 4.8B-RMB 5.1B 11/30/22 XPeng reports Q3 EPS (36c), consensus (36c) 01/31/23 UBS reports Q4 EPS 50c, profit before tax $1.9B 10/25/22 UBS reports Q3 EPS 52c, net profit $1.7B 03/02/23 Stratasys sees FY23 EPS 12c-24c, consensus 20c 03/02/23 Stratasys reports Q4 EPS 7c, consensus 3c 11/10/22 Stratasys sees FY22 EPS 9c-12c, consensus 14c 02/23/23 Block reports Q4 EPS 22c, consensus 30c 02/23/23 Notable companies reporting after market close 11/03/22 Block reports Q3 adjusted EPS 42c, consensus 23c 11/03/22 Notable companies reporting after market close 03/10/23 Compugen considers exposure to SVB Financial as immaterial 01/19/23 SVB Financial reports Q4 EPS $4.62, consensus $5.27 10/20/22 SVB Financial reports Q3 EPS $7.21, consensus $6.95 03/24/23 Stifel Financial sees Q1 investment banking revenue down 5%-10% from Q4 01/25/23 Stifel Financial reports Q4 adjusted EPS $1.58, consensus $1.64 10/26/22 Stifel Financial reports Q3 adjusted EPS $1.29, consensus $1.45 03/23/23 Scholastic cuts FY23 revenue growth view to about 4% from 8%-10% 03/23/23 Scholastic reports Q3 EPS (57c) vs. (44c) last year 12/15/22 Scholastic backs FY23 revenue growth 8%-10% 12/15/22 Scholastic reports Q2 EPS $2.12 vs. $1.91 a year ago $820.34 / +17.72 (+2.21%)
02/03/23 Regeneron reports Q4 adjusted EPS $12.56, consensus $10.03 02/02/23 Notable companies reporting before tomorrow's open 01/09/23 Regeneron sees about $1.5B in Q4 U.S. net product sales of Eylea 03/24/23 Oncorus reports Q4 EPS (81c), consensus (76c) 11/02/22 Oncorus reports Q3 EPS (76c), consensus (75c) 01/24/23 Nano Dimension reports Q4 revenue $12.1M, up 61% vs. 4Q21 12/01/22 Nano Dimension reports Q3 EPS (26c) vs. (7c) last year 10/24/22 Nano Dimension sees Q3 revenue $10M 01/24/23 Microsoft reports Q2 adjusted EPS $2.32, consensus $2.29 01/24/23 Notable companies reporting after market close 10/25/22 Microsoft sees FX decreasing total revenue growth by 5% in FY23 10/25/22 Microsoft reports Q1 EPS $2.35, consensus $2.30 03/23/23 Altria Group affirms FY23 EPS view of $4.98-$5.13, consensus $5.06 02/01/23 Altria Group sees FY23 adjusted EPS $4.98-$5.13, consensus $5.05 02/01/23 Altria Group reports Q4 adjusted EPS $1.18, consensus $1.17 01/31/23 Notable companies reporting before tomorrow's open $205.99 / +1.695 (+0.83%)
02/01/23 Meta Platforms sees Q1 revenue $26B-$28.5B, consensus $27.14B 02/01/23 Meta Platforms reports Q4 EPS $1.76, consensus $2.22 02/01/23 Notable companies reporting after market close 11/09/22 Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B 03/24/23 Leap Therapeutics reports Q4 EPS (11c), consensus (11c) 11/14/22 Leap Therapeutics reports Q3 EPS (13c), consensus (12c) 01/13/23 JPMorgan reports Q4 EPS $3.57, consensus $3.07 01/12/23 Notable companies reporting before tomorrow's open 10/14/22 JPMorgan reports Q3 EPS $3.12, consensus $2.88 03/23/23 Joann reports Q4 EPS 7c, may not compare to consensus 70c 12/12/22 Joann reports Q3 adjusted EPS 6c, consensus 23c IMPL Impel Pharmaceuticals 03/24/23 Impel Pharmaceuticals reports Q4 adjusted EPS (97c), consesnus ($1.11) 11/14/22 Impel Pharmaceuticals reports Q3 EPS ($1.31), consensus ($1.00) 03/24/23 Humacyte reports Q4 EPS (4c), consensus (23c) 11/10/22 Humacyte reports Q3 EPS (25c), consensus (21c) 02/23/23 Farfetch sees FY23 adjusted EBITDA margin 1%-3% 02/23/23 Farfetch reports Q4 adjusted EPS (25c), consensus (47c) 11/17/22 Farfetch reports Q3 adjusted EPS (24c), consensus (28c) 02/02/23 Deutsche Bank reports Q4 profit before tax EUR 775M vs. EUR 82M last year 10/26/22 Deutsche Bank reaffirms 2022 revenue guidance of EUR26B-EUR27B 10/26/22 Deutsche Bank reports Q3 profit before tax EUR 1.6B, post-tax profit EUR 1.2B 02/21/23 Coinbase reports Q4 EPS ($2.46) vs. $3.32 y/y 02/21/23 Notable companies reporting after market close 01/10/23 Coinbase sees FY22 adjusted EBITDA within negative $500M loss 'guardrail' 12/07/22 Coinbase CEO tells Bloomberg 2022 revenue seen down 50% or more 02/02/23 Clorox raises FY23 adjusted EPS view to $4.05-$4.30 from $3.85-$4.22 02/02/23 Clorox reports Q2 adjusted EPS 98c, consensus 65c 02/02/23 Notable companies reporting after market close 11/01/22 Clorox backs FY23 adjusted EPS view $3.85-$4.22, consensus $4.07 01/13/23 Bank of America reports Q4 EPS 85c, consensus 77c 10/17/22 Bank of America reports Q3 EPS 81c, consensus 77c 02/06/23 Activision Blizzard reports Q4 adjusted EPS $1.09, consensus $1.51 02/06/23 Notable companies reporting after market close 11/07/22 Activision Blizzard reports Q3 adjusted EPS 68c, consensus 50c 11/07/22 Notable companies reporting after market close AMPX Amprius Technologies 03/23/23 Amprius Technologies reports Q4 EPS (7c), consensus (6c) 01/26/23 American Airlines sees Q1 adjusted EPS approx. breakeven, consensus 1c 01/26/23 American Airlines sees 2023 adjusted EPS $2.50-$3.50, consensus $1.77 01/26/23 American Airlines reports Q4 EPS ex-items $1.17, consensus $1.14 01/25/23 Notable companies reporting before tomorrow's open
On The Fly
Get caught up quickly on…
Show Hide Related Items >> <<
03/17/23 XPeng rises 10.8% 03/17/23 XPeng announces 5,218 vehicles delivered in January 03/10/23 XPeng laiuches P7i sports sedan in China 03/01/23 XPeng delivers 6,010 Smart EVs in February 03/20/23 S&P revises UBS Group outlook to Negative, affirms ratings 03/20/23 UBS rises 7.9% 03/19/23 Credit Suisse says UBS confident staff employment will be continued 03/22/23 Stratasys up 4.5% at $15.25 as its board rejects Nano Dimension offer 03/13/23 Nano Dimension CEO provides rationale for acquisition of Stratasys 03/24/23 Block continues selloff, shares down 4% to $59.31 03/23/23 Cathie Wood's ARK Investment bought 338K shares of Block today 03/23/23 Block exploring legal action against Hindenburg after 'misleading' report 03/23/23 Block calls Hindenburg report 'factually inaccurate and misleading' 03/23/23 Stifel Financial announces significant expansion of venture banking business 03/22/23 Senators Scott, Warren unveil bipartisan Fed oversight legislation 03/22/23 Stronghold Digital reports no direct exposure to SVB, Signature, Silvergate 03/20/23 WhiteHorse Finance says no exposure to Silicon Valley Bank or Signature Bank 03/01/23 Stifel Financial closes acquisition of Torreya partners 02/16/23 Stifel Financial announces launch of an ASPG, new hires 01/31/23 Eaton Partners acts as exclusive placement agent for SKY Leasing Fund V $31.15 / -10.14 (-24.56%)
03/23/23 Scholastic falls 11% to $36.90 after lowering FY23 guidance 03/23/23 Scholastic board authorizes additional $50M for share repurchases 02/22/23 Scholastic announces strategic partnership with SoapBox Labs 12/15/22 Scholastic raises share repurchase authorization to $75M 02/13/23 ReNew Energy to rebrand as ReNew 12/16/22 ReNew Energy Global signs 150 MW agreement with Microsoft 03/23/23 Regeneron, Sanofi report Dupixent trial meets primary and secondary endpoints 03/22/23 Regeneron announces FDA approval of Evkeeza for young children 03/21/23 Regeneron, Sanofi announce EC approval of Dupixent 03/19/23 Regeneron, Sanofi present results from Dupixent clinical trial 03/24/23 Oncorus expects cash to fund expenditures into early 2024 03/10/23 Oncorus informs investors of holdings with SVB Financial 01/04/23 Oncorus announces research collaboration with Daewoong Pharmaceutical 11/30/22 Oncorus announces reprioritization of lead product candidate ONCR-021 03/23/23 Nano Dimension to review options relative to Stratasys and alternative targets 03/23/23 Nano Dimension releases video on products, materials, technologies 03/22/23 Stratasys board unanimously rejects acquisition proposal from Nano Dimension 03/21/23 Nano Dimension responds to Murchinson claims about shareholder meeting results 03/22/23 Microsoft, CarbonCapture reach carbon removal credits agreement 03/22/23 Syneos Health and KX team on predictive analytics, AI and ML 03/21/23 Nvidia says Nvidia Omniverse Cloud now available to select enterprises 03/06/23 Altria Group to acquire NJOY Holdings for $2.75B in cash 03/03/23 Altria Group exchanges minority stake in JUUL Labs for heated tobacco IP rights 01/24/23 Altria Group trading resumes 01/24/23 Altria Group trading halted, volatility trading pause $205.93 / +1.635 (+0.80%)
03/21/23 Nvidia announces availability of new products featuring H100 Tensor Core GPU 03/15/23 Facebook Ireland violated law over data use, Amsterdam court ruled 03/15/23 Oportun Financial expands executive team with key new hires 03/14/23 Meta targeting summer to complete analysis from hybrid work year of learning 03/16/23 Leap Therapeutics provides update on BeiGene option agreement for DKN-01 01/17/23 Leap Therapeutics acquires Flame Biosciences 11/07/22 Leap Therapeutics' DKN-01 demonstrates preclinical tumor regression in study 10/17/22 Leap Therapeutics enrolls first patient in study of colorectal cancer candidate 03/22/23 JPMorgan to acquire Aumni, terms not disclosed 03/21/23 Campbell Lutyens and J.P. Morgan announce collaboration in 2NDRY advisory market 03/19/23 Fly Intel: Top five weekend stock stories 03/16/23 First Republic confirms it will receive deposits totaling $30B from banks 03/13/23 Joann announces $100M FILO credit facility 10/10/22 Joann, Sutton Foster team up for World Mental Health Day IMPL Impel Pharmaceuticals 03/24/23 Impel Pharmaceuticals sees Trudhesa delivering 80K-110K TRx for 2023 03/24/23 Impel Pharmaceuticals expects cash to fund operations into 3Q23 02/22/23 Impel Pharmaceuticals announces strategic reprioritization, departure of CMO 09/28/22 Impel Pharmaceuticals Inc trading resumes 03/24/23 Humacyte expects cash to fund operations through 2024 01/24/23 Humacyte announces publication of 6-year outcomes in Phase 2 study of HAV 12/13/22 Humacyte hosts KOL webinar on vascular trauma 11/10/22 Humacyte expects cash to fund operations through 2024 03/24/23 Farfetch falls -8.1% 02/24/23 Farfetch rises 13.0% 02/23/23 Farfetch CFO Jordan to step down by end of 2023 01/18/23 Farfetch announces changes to leadership team 03/24/23 Deutsche Bank falls -6.7% 03/24/23 Deutsche Bank falls -6.5% 03/22/23 Deutsche Bank raises prime lending rate to 8.00% from 7.75%, effective March 23 02/02/23 Deutsche Bank reaffirms financial targets for 2025 03/02/23 Salesforce rises 11.8% 03/02/23 Salesforce rises 13.4% 03/02/23 Salesforce rises 14.2% 03/01/23 Elliott says Salesforce's announcements represent 'progress' 03/23/23 Cathie Wood's ARK Investment bought 269K shares of Coinbase today 03/22/23 Coinbase says 'we are confident in the legality of our assets and services' 03/22/23 Coinbase falls 7% to $71.70 after announcing Wells Notice from SEC 03/22/23 Coinbase receives Wells Notice from SEC 02/03/23 Clorox rises 9.6% 02/02/23 Clorox sees FX headwinds a 2-point reduction to FY23 sales 02/02/23 Clorox CEO says 'actions we are taking to rebuild margin are working' 02/02/23 Clorox reports Q2 gross margin up 320 bps to 36.2% from 33% a year ago 03/24/23 CMA 'narrows scope of concerns' in Microsoft-Activision review 03/15/23 Microsoft signs 10-year Xbox PC game partnership with Ubitus 03/14/23 Blizzard's Ferguson says 'no plans' for 'Diablo IV' on Game Pass 03/10/23 Sony says 'Hogwarts Legacy' most downloaded PS5 game in February AMPX Amprius Technologies 03/24/23 Amprius Technologies falls -8.0% 03/24/23 Amprius Technologies rises 6.8% 03/23/23 Amprius Technologies says will be 'limited by manufacturing capacity' 03/06/23 Amprius Technologies selects Colorado for new facility 03/14/23 Apple launches Shop with a Specialist over Video 03/09/23 Apple says Apple Music Classical releases March 28 03/08/23 Apple backs new music startup Gamma 03/07/23 Sonos to add support for spatial audio on Apple Music 02/10/23 BofA Deutsche Bank downgraded to Underperform from Neutral at BofA 02/08/23 UBS Deutsche Bank price target raised to EUR 18.80 from EUR 16.30 at UBS 02/03/23 Credit Suisse Deutsche Bank price target raised to EUR 11 from EUR 10.50 at Credit Suisse 01/13/23 Barclays Deutsche Bank price target raised to EUR 12.50 from EUR 11.50 at Barclays 11/10/22 UBS UBS downgrades Altria to Sell on consumer trade down risk 11/10/22 UBS Altria Group downgraded to Sell from Neutral at UBS 11/02/22 Morgan Stanley Philip Morris price target raised to $109 from $102 at Morgan Stanley 10/28/22 Stifel Altria JV news trumps 'rare' EPS miss, says Stifel 03/20/23 Deutsche Bank Clorox price target lowered to $147 from $152 at Deutsche Bank 02/16/23 Citi Citi launches beverage, personal space with six buys, two sells 02/16/23 Citi Clorox initiated with a Neutral at Citi 02/06/23 Barclays Clorox price target lowered to $108 from $110 at Barclays $31.15 / -10.14 (-24.56%)
03/24/23 Loop Capital Joann price target lowered to $2 from $4 at Loop Capital 12/14/22 Barclays Joann price target lowered to $3 from $5 at Barclays 12/13/22 Loop Capital Joann price target lowered to $4 from $7 at Loop Capital 09/02/22 Wells Fargo Joann price target lowered to $4 from $5 at Wells Fargo 03/24/23 RBC Capital JPMorgan price target lowered to $132 from $150 at RBC Capital 03/13/23 Wells Fargo Wells Fargo upgrades JPMorgan on 'Goliath is Winning' theme 03/13/23 Wells Fargo JPMorgan upgraded to Overweight from Equal Weight at Wells Fargo 02/24/23 Morgan Stanley JPMorgan price target raised to $173 from $167 at Morgan Stanley 03/24/23 Morgan Stanley nCino price target lowered to $27 from $35 at Morgan Stanley 03/23/23 Raymond James Block short report doesn't include 'bombshell,' says Raymond James 03/22/23 BofA Regional bank distress gives CME Group a new growth opportunity, says BofA 03/20/23 Benchmark Aspen Aerogels upgraded to Buy from Hold at Benchmark $205.93 / +1.635 (+0.80%)
03/24/23 JPMorgan Meta Platforms price target raised to $270 from $225 at JPMorgan 03/24/23 Barclays Meta Platforms price target raised to $270 from $260 at Barclays 03/22/23 KeyBanc Meta Platforms upgraded to Overweight from Sector Weight at KeyBanc 03/21/23 Morgan Stanley Meta Platforms upgraded to Overweight from Equal Weight at Morgan Stanley 03/21/23 Morgan Stanley Microsoft app store longer-term Apple risk 'worth watching,' says Morgan Stanley 03/16/23 Susquehanna Qualcomm upgraded at Susquehanna with China opening, Apple 'de-risked' 03/14/23 Evercore ISI Apple premium to big tech 'justified,' could expand further, says Evercore ISI 03/10/23 LightShed Partners Apple cut to Sell at LightShed on more conservative outlook for iPhone sales 03/09/23 Needham Vertex price target raised to $25 from $19 at Needham 03/03/23 Citi Salesforce price target raised to $210 from $182 at Citi 03/02/23 BMO Capital Salesforce price target raised to $230 from $185 at BMO Capital 03/02/23 Truist Salesforce price target raised to $250 from $210 at Truist 03/10/23 Lake Street Nano Dimension made 'lowball offer' Stratasys won't accept, says Lake Street 03/03/23 Lake Street Stratasys price target raised to $22 from $20 at Lake Street 01/04/23 Needham Needham upgrades Stratasys to Buy, sees valuation reflect more challenging 2023 01/04/23 Needham Stratasys upgraded to Buy from Hold at Needham 02/16/23 Deutsche Bank Deutsche upgrades Activision to Buy, says best risk/reward in gaming 02/16/23 Deutsche Bank Activision Blizzard upgraded to Buy from Hold at Deutsche Bank 02/10/23 Roth MKM Activision Blizzard price target lowered to $88 from $95 at Roth MKM 03/20/23 Stifel Alphabet resumed with a Buy at Stifel 03/20/23 Evercore ISI Microsoft price target raised to $295 from $280 at Evercore ISI 03/17/23 Mizuho Microsoft price target raised to $315 from $300 at Mizuho AMPX Amprius Technologies 12/02/22 B. Riley B. Riley starts 'early battery winner' Amprius with Buy, $14 target 12/01/22 B. Riley Amprius Technologies initiated with a Buy at B. Riley 10/27/22 EF Hutton Amprius Technologies initiated with a Buy at EF Hutton 10/13/22 Oppenheimer Amprius Technologies initiated with an Outperform at Oppenheimer 03/23/23 Nomura VNET Group downgraded to Neutral from Buy at Nomura 09/01/22 Credit Suisse Credit Suisse downgrades VNET Group to Neutralm lowers target to $5.90 09/01/22 Credit Suisse VNET Group downgraded to Neutral from Outperform at Credit Suisse 05/25/22 HSBC VNET Group price target lowered to $9.40 from $13.50 at HSBC 03/24/23 Citi Farfetch price target lowered to $4 from $6 at Citi 03/24/23 JMP Securities Farfetch initiated with a Market Perform at JMP Securities 01/30/23 KeyBanc KeyBanc keeps Overweight on Farfetch, lowers price target to $11 12/15/22 Oppenheimer Farfetch price target lowered to $7 from $14 at Oppenheimer IMPL Impel Pharmaceuticals 11/15/22 Wedbush Wedbush downgrades Impel Pharmaceuticals to Neutral, lowers price target to $5 11/15/22 Wedbush Impel Pharmaceuticals downgraded to Neutral from Outperform at Wedbush 08/24/22 JonesResearch Impel Pharmaceuticals initiated with a Buy at JonesTrading 01/12/23 Citi Stifel Financial price target raised to $65 from $60 at Citi 01/10/23 JMP Securities Stifel Financial price target lowered to $95 from $98 at JMP Securities 11/22/22 UBS Stifel Financial initiated with a Neutral at UBS 10/12/22 Citi Citi starts exchanges and brokers with CME, MarketAxess among top picks 12/06/22 H.C. Wainwright Oncorus downgraded to Neutral from Buy at H.C. Wainwright 11/30/22 Chardan Oncorus downgraded to Neutral from Buy at Chardan 11/30/22 Piper Sandler Piper downgrades Oncorus with plug pulled on lead program 11/30/22 Piper Sandler Oncorus downgraded to Neutral from Overweight at Piper Sandler 03/17/23 Piper Sandler Leap Therapeutics news 'disappointing at first glance,' says Piper Sandler 03/17/23 Mizuho Leap Therapeutics price target lowered to $2 from $3 at Mizuho 01/27/23 Mizuho Leap Therapeutics price target lowered to $3 from $6 at Mizuho 01/17/23 Piper Sandler Leap Therapeutics price target lowered to $3 from $4 at Piper Sandler 03/12/23 BTIG BTIG finds medical technology stocks with exposure with SVB 12/19/22 TD Cowen Humacyte price target lowered to $5 from $8 at Cowen 11/10/22 Piper Sandler Humacyte price target lowered to $2.75 from $3.50 at Piper Sandler 10/12/22 Piper Sandler CMS proposal a positive for Med Tech sector, says Piper Sandler 03/24/23 Compass Point Coinbase Wells notice fight will take 'years to resolve,' says Compass Point 03/24/23 TD Cowen Coinbase downgraded to Underperform from Market Perform at TD Cowen 03/23/23 BofA SEC action to weigh on Coinbase shares, says BofA 03/23/23 Jefferies Coinbase Wells notice likely precursor to enforcement action, says Jefferies 03/24/23 Oppenheimer Oppenheimer remains on the sidelines for Block after short report 03/24/23 BofA Block shares 'overreacting' to short seller report, says BofA 03/24/23 Citi Block short seller response likely not enough, says Citi 03/24/23 Atlantic Equities Atlantic Equities downgrades Block pending more clarity on short report 03/24/23 Bernstein XPeng downgraded to Market Perform from Outperform at Bernstein 03/24/23 Bernstein XPeng downgraded to Market Perform from Outperform at Bernstein 03/20/23 Morgan Stanley XPeng price target raised to $12.50 from $12 at Morgan Stanley 03/20/23 Morgan Stanley Li Auto price target raised to $30 from $23 at Morgan Stanley 03/24/23 BMO Capital Regeneron price target raised to $1,040 from $1,025 at BMO Capital 03/24/23 Wells Fargo Regeneron price target raised to $915 from $860 at Wells Fargo 03/24/23 Baird Regeneron price target raised to $800 from $756 at Baird 03/24/23 Barclays Regeneron price target raised to $915 from $815 at Barclays 03/24/23 Jefferies UBS downgraded to Hold from Buy at Jefferies 03/20/23 Barclays European Banks sector view downgraded to Neutral at Barclays 03/20/23 Societe Generale UBS downgraded to Hold from Buy at Societe Generale 03/20/23 Keefe Bruyette UBS downgraded to Underperform from Market Perform at Keefe Bruyette 03/17/23 XPeng sees Q1 revenue down 43.7%-46.3%, consensus $882.99M 03/17/23 XPeng reports Q4 adjusted EPS (37c), consensus (36c) 11/30/22 XPeng sees Q4 revenue RMB 4.8B-RMB 5.1B 11/30/22 XPeng reports Q3 EPS (36c), consensus (36c) 01/31/23 UBS reports Q4 EPS 50c, profit before tax $1.9B 10/25/22 UBS reports Q3 EPS 52c, net profit $1.7B 03/02/23 Stratasys sees FY23 EPS 12c-24c, consensus 20c 03/02/23 Stratasys reports Q4 EPS 7c, consensus 3c 11/10/22 Stratasys sees FY22 EPS 9c-12c, consensus 14c 02/23/23 Block reports Q4 EPS 22c, consensus 30c 11/03/22 Block reports Q3 adjusted EPS 42c, consensus 23c 11/03/22 Notable companies reporting after market close 03/10/23 Compugen considers exposure to SVB Financial as immaterial 01/19/23 SVB Financial reports Q4 EPS $4.62, consensus $5.27 10/20/22 SVB Financial reports Q3 EPS $7.21, consensus $6.95 03/24/23 Stifel Financial sees Q1 investment banking revenue down 5%-10% from Q4 01/25/23 Stifel Financial reports Q4 adjusted EPS $1.58, consensus $1.64 10/26/22 Stifel Financial reports Q3 adjusted EPS $1.29, consensus $1.45 $31.15 / -10.14 (-24.56%)
03/23/23 Scholastic cuts FY23 revenue growth view to about 4% from 8%-10% 03/23/23 Scholastic reports Q3 EPS (57c) vs. (44c) last year 12/15/22 Scholastic backs FY23 revenue growth 8%-10% 12/15/22 Scholastic reports Q2 EPS $2.12 vs. $1.91 a year ago 02/03/23 Regeneron reports Q4 adjusted EPS $12.56, consensus $10.03 02/02/23 Notable companies reporting before tomorrow's open 01/09/23 Regeneron sees about $1.5B in Q4 U.S. net product sales of Eylea 03/24/23 Oncorus reports Q4 EPS (81c), consensus (76c) 11/02/22 Oncorus reports Q3 EPS (76c), consensus (75c) 01/24/23 Nano Dimension reports Q4 revenue $12.1M, up 61% vs. 4Q21 12/01/22 Nano Dimension reports Q3 EPS (26c) vs. (7c) last year 10/24/22 Nano Dimension sees Q3 revenue $10M 01/24/23 Microsoft reports Q2 adjusted EPS $2.32, consensus $2.29 01/24/23 Notable companies reporting after market close 10/25/22 Microsoft sees FX decreasing total revenue growth by 5% in FY23 10/25/22 Microsoft reports Q1 EPS $2.35, consensus $2.30 03/23/23 Altria Group affirms FY23 EPS view of $4.98-$5.13, consensus $5.06 02/01/23 Altria Group sees FY23 adjusted EPS $4.98-$5.13, consensus $5.05 02/01/23 Altria Group reports Q4 adjusted EPS $1.18, consensus $1.17 01/31/23 Notable companies reporting before tomorrow's open $205.93 / +1.635 (+0.80%)
02/01/23 Meta Platforms sees Q1 revenue $26B-$28.5B, consensus $27.14B 02/01/23 Meta Platforms reports Q4 EPS $1.76, consensus $2.22 02/01/23 Notable companies reporting after market close 11/09/22 Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B 03/24/23 Leap Therapeutics reports Q4 EPS (11c), consensus (11c) 11/14/22 Leap Therapeutics reports Q3 EPS (13c), consensus (12c) 01/13/23 JPMorgan reports Q4 EPS $3.57, consensus $3.07 01/12/23 Notable companies reporting before tomorrow's open 10/14/22 JPMorgan reports Q3 EPS $3.12, consensus $2.88 03/23/23 Joann reports Q4 EPS 7c, may not compare to consensus 70c 12/12/22 Joann reports Q3 adjusted EPS 6c, consensus 23c IMPL Impel Pharmaceuticals 03/24/23 Impel Pharmaceuticals reports Q4 adjusted EPS (97c), consesnus ($1.11) 11/14/22 Impel Pharmaceuticals reports Q3 EPS ($1.31), consensus ($1.00) 03/24/23 Humacyte reports Q4 EPS (4c), consensus (23c) 11/10/22 Humacyte reports Q3 EPS (25c), consensus (21c) 02/23/23 Farfetch sees FY23 adjusted EBITDA margin 1%-3% 02/23/23 Farfetch reports Q4 adjusted EPS (25c), consensus (47c) 02/23/23 Notable companies reporting after market close 11/17/22 Farfetch reports Q3 adjusted EPS (24c), consensus (28c) 02/02/23 Deutsche Bank reports Q4 profit before tax EUR 775M vs. EUR 82M last year 10/26/22 Deutsche Bank reaffirms 2022 revenue guidance of EUR26B-EUR27B 10/26/22 Deutsche Bank reports Q3 profit before tax EUR 1.6B, post-tax profit EUR 1.2B 03/01/23 Salesforce guides initial FY24 EPS $7.12-7.14, consensus $5.84 03/01/23 Salesforce sees Q1 EPS $1.60-$1.61, consensus $1.32 03/01/23 Salesforce reports Q4 EPS $1.68, consensus $1.36 03/01/23 Notable companies reporting after market close 02/21/23 Coinbase reports Q4 EPS ($2.46) vs. $3.32 y/y 02/21/23 Notable companies reporting after market close 01/10/23 Coinbase sees FY22 adjusted EBITDA within negative $500M loss 'guardrail' 12/07/22 Coinbase CEO tells Bloomberg 2022 revenue seen down 50% or more 02/02/23 Clorox raises FY23 adjusted EPS view to $4.05-$4.30 from $3.85-$4.22 02/02/23 Clorox reports Q2 adjusted EPS 98c, consensus 65c 02/02/23 Notable companies reporting after market close 11/01/22 Clorox backs FY23 adjusted EPS view $3.85-$4.22, consensus $4.07 02/06/23 Activision Blizzard reports Q4 adjusted EPS $1.09, consensus $1.51 02/06/23 Notable companies reporting after market close 11/07/22 Activision Blizzard reports Q3 adjusted EPS 68c, consensus 50c 11/07/22 Notable companies reporting after market close AMPX Amprius Technologies 03/23/23 Amprius Technologies reports Q4 EPS (7c), consensus (6c) 02/02/23 Apple reports Q1 EPS $1.88, consensus $1.94 10/27/22 Apple reports Q4 EPS $1.29, consensus $1.17 10/27/22 Notable companies reporting after market close
On The Fly
Want to get stock-moving…
Show Hide Related Items >> <<
03/21/23 EU passenger car registrations up 11.5% in February 03/16/23 Volkswagen unveils all-electric ID. 2all concept car 03/14/23 Volkswagen: BEV deliveries rose 26% in 2022 03/14/23 Volkswagen to invest EUR180B over 5 years in 'attractive' profit pools 03/09/23 Vital Farms releases three ESG goals its aiming to hit in next five years 02/17/23 Vital Farms launches new relationship with Dot Foods 02/13/23 Vital Farms partners with True Food Kitchen to serve pasture-raised eggs 02/08/23 Vital Farms appoints Wrede as Chief Financial Officer 03/20/23 S&P revises UBS Group outlook to Negative, affirms ratings 03/20/23 UBS rises 7.9% 03/19/23 Fly Intel: Top five weekend stock stories 03/19/23 Credit Suisse says UBS confident staff employment will be continued 03/01/23 Cowen Group announces completion of acquisition by TD Bank 03/01/23 TD Bank completes acquisition of Cowen Group $61.90 / -10.735 (-14.78%)
03/24/23 Block continues selloff, shares down 4% to $59.31 03/23/23 Cathie Wood's ARK Investment bought 338K shares of Block today 03/23/23 Block exploring legal action against Hindenburg after 'misleading' report 03/23/23 Block calls Hindenburg report 'factually inaccurate and misleading' 02/16/23 RingCentral falls -23.2% 02/16/23 RingCentral falls -23.5% 02/16/23 RingCentral falls -19.1% 02/15/23 Amazon.com, RingCentral enter strategic collaboration $802.35 / +47.93 (+6.35%)
03/23/23 Regeneron, Sanofi report Dupixent trial meets primary and secondary endpoints 03/22/23 Regeneron announces FDA approval of Evkeeza for young children 03/21/23 Regeneron, Sanofi announce EC approval of Dupixent 03/19/23 Regeneron, Sanofi present results from Dupixent clinical trial 03/13/23 MDxHealth confirms no exposure to SVB Financial, Silvergate Capital 02/13/23 MDxHealth: UnitedHealth to provide commercial coverage for GPs test 02/03/23 MDxHealth announces pricing of offering of ADSs in the U.S. 01/09/23 MDxHealth backs FY23 revenue view $65M-$70M, consensus $65.36M 01/27/23 Legend Biotech says Carvykti myeloma study met primary endpoint 01/02/23 Legend says China accepts ciltacabtagene New Drug Application 11/21/22 FDA clears Legend Biotech's IND application for LB2102 to treat extensive NSLC 11/03/22 Legend Biotech announces seven studies accepted for presentation at ASH $154.30 / -8.525 (-5.24%)
03/22/23 Genuine Parts announces strategic partnership with Google Cloud 02/21/23 Genuine Parts raises quarterly dividend 6% to 95c per share 12/07/22 Genuine Parts names Will Stengel President and COO 02/24/23 Farfetch rises 13.0% 02/23/23 Farfetch CFO Jordan to step down by end of 2023 01/18/23 Farfetch announces changes to leadership team 12/29/22 Farfetch rises 11.7% 03/13/23 First Horizon trading resumes 03/13/23 First Horizon trading halted, volatility trading pause 03/02/23 TD Bank, First Horizon continuing to engage with regulators on applications 03/01/23 First Horizon, TD extend outside date for pending merger 03/21/23 Chubb says does not have exposure to any Credit Suisse AT1 bonds 03/14/23 Crane announces Paul Igoe appointed General Counsel of Crane NXT 03/08/23 Crane announces timing of previously announced separation 02/07/23 Crane announces effectiveness of Form 10 for Crane Company 10/20/22 Crane names Aaron Saak CEO of Crane NXT $66.28 / -10.96 (-14.19%)
03/23/23 Cathie Wood's ARK Investment bought 269K shares of Coinbase today 03/22/23 Coinbase says 'we are confident in the legality of our assets and services' 03/22/23 Coinbase falls 7% to $71.70 after announcing Wells Notice from SEC 03/22/23 Coinbase receives Wells Notice from SEC 03/20/23 S&P announces changes to S&P 400, 600 indices at open on 3/20 12/02/22 Cracker Barrel falls 5% to $107.50 after Q1 results FY23 guidance 09/28/22 Cracker Barrel, Biglari announce cooperation agreement 02/06/23 Reed asked FTC to crack down on possible egg price gouging 01/19/23 Cal-Maine Foods in partnership with Entegrity to install solar array 12/28/22 Cal-Maine Foods says HPAI outlook to continue exert pressure on egg supply 12/28/22 Cal-Maine Foods says egg prices continue to move higher due to reduced supply 01/31/23 Axonics receives FDA approval for rechargeable sacral neuromodulation system 12/13/22 Axonics announces Health Canada approval of R20 neurostimulator 10/31/22 Axonics falls 7% to $67.90 after Q3 results and guidance 03/24/23 Citi Farfetch price target lowered to $4 from $6 at Citi 03/24/23 JMP Securities Farfetch initiated with a Market Perform at JMP Securities 01/30/23 KeyBanc KeyBanc keeps Overweight on Farfetch, lowers price target to $11 12/15/22 Oppenheimer Farfetch price target lowered to $7 from $14 at Oppenheimer 03/24/23 Wells Fargo Wells Fargo upgrades First Horizon with 60% upside to deal price 03/24/23 Wells Fargo First Horizon upgraded to Overweight from Equal Weight at Wells Fargo 03/03/23 Jefferies TD price negotiation on First Horizon 'not off table,' say Jefferies 03/03/23 Scotiabank TD upgraded to Outperform after 'excessive' selloff at Scotiabank 03/03/23 Barclays TD Bank price target lowered to C$101 from C$102 at Barclays $61.90 / -10.735 (-14.78%)
03/24/23 Oppenheimer Oppenheimer remains on the sidelines for Block after short report 03/24/23 BofA Block shares 'overreacting' to short seller report, says BofA 03/24/23 Citi Block short seller response likely not enough, says Citi 03/24/23 Atlantic Equities Atlantic Equities downgrades Block pending more clarity on short report $66.28 / -10.96 (-14.19%)
03/24/23 Compass Point Coinbase Wells notice fight will take 'years to resolve,' says Compass Point 03/24/23 TD Cowen Coinbase downgraded to Underperform from Market Perform at TD Cowen 03/23/23 BofA SEC action to weigh on Coinbase shares, says BofA 03/23/23 Jefferies Coinbase Wells notice likely precursor to enforcement action, says Jefferies 03/24/23 UBS Crane downgraded to Neutral into NXT separation at UBS 03/24/23 UBS Crane downgraded to Neutral from Buy at UBS 01/25/23 DA Davidson Crane price target raised to $140 from $130 at DA Davidson 12/12/22 Morgan Stanley Crane upgraded to Overweight from Equal Weight at Morgan Stanley $154.30 / -8.525 (-5.24%)
03/24/23 Truist Truist upgrades Genuine Parts on improved risk/reward post selloff 03/24/23 Truist Genuine Parts upgraded to Buy from Hold at Truist 02/24/23 Truist Genuine Parts price target raised to $186 from $170 at Truist 02/23/23 Goldman Sachs Genuine Parts price target raised to $157 from $147 at Goldman Sachs $802.35 / +47.93 (+6.35%)
03/24/23 BMO Capital Regeneron price target raised to $1,040 from $1,025 at BMO Capital 03/24/23 Wells Fargo Regeneron price target raised to $915 from $860 at Wells Fargo 03/24/23 Baird Regeneron price target raised to $800 from $756 at Baird 03/24/23 Barclays Regeneron price target raised to $915 from $815 at Barclays 03/24/23 Argus Argus upgrades Cracker Barrel to Buy on increased sales from new menu items 03/24/23 Argus Cracker Barrel upgraded to Buy from Hold at Argus 03/01/23 Deutsche Bank Cracker Barrel price target raised to $110 from $100 at Deutsche Bank 03/01/23 CL King Cracker Barrel price target raised to $130 from $125 at CL King 03/24/23 Jefferies UBS downgraded to Hold from Buy at Jefferies 03/20/23 Barclays European Banks sector view downgraded to Neutral at Barclays 03/20/23 Societe Generale UBS downgraded to Hold from Buy at Societe Generale 03/20/23 Keefe Bruyette UBS downgraded to Underperform from Market Perform at Keefe Bruyette 03/20/23 BofA UBS upgraded to Buy from Neutral at BofA 03/24/23 Stifel Volkswagen downgraded to Hold from Buy at Stifel 03/21/23 Morgan Stanley EV price cuts 'not a fad, but a trend,' says Morgan Stanley 03/07/23 Deutsche Bank Volkswagen price target raised to EUR 190 from EUR 180 at Deutsche Bank 03/03/23 HSBC Volkswagen downgraded to Hold from Buy at HSBC 03/23/23 Rosenblatt RingCentral initiated with a Buy at Rosenblatt 03/17/23 Oppenheimer RingCentral downgraded to Perform from Outperform at Oppenheimer 02/24/23 Jefferies RingCentral price target lowered to $45 from $50 at Jefferies 02/21/23 Mizuho RingCentral price target lowered to $45 from $50 at Mizuho 03/24/23 William Blair William Blair starts prostate cancer 'pure-play' MDxHealth at Outperform 03/24/23 William Blair MDxHealth initiated with an Outperform at William Blair 03/09/23 BTIG MDxHealth price target lowered to $8 from $12 at BTIG 03/06/23 Piper Sandler MDxHealth price target lowered to $10 from $15 at Piper Sandler 03/24/23 Needham Needham upgrades Axonics to Buy on conservative guidance, attractive valuation 03/24/23 Needham Axonics upgraded to Buy from Hold at Needham 11/01/22 Truist Axonics price target raised to $90 from $80 at Truist 11/01/22 Wells Fargo Axonics price target raised to $90 from $83 at Wells Fargo 03/24/23 Lake Street Vital Farms initiated with a Buy at Lake Street 09/30/22 UBS Vital Farms initiated with a Buy at UBS 07/20/22 Morgan Stanley Vital Farms upgraded to Overweight from Equal Weight at Morgan Stanley 05/06/22 BMO Capital Vital Farms price target lowered to $15 from $20 at BMO Capital 12/29/22 BofA Cal-Maine earnings miss to weigh on shares, says BofA 09/28/22 BofA Cal-Maine Foods price target lowered to $50 from $55 at BofA 03/30/22 Consumer Edge Cal-Maine Foods upgraded to Overweight from Equal Weight at Consumer Edge 03/24/23 RBC Capital Legend Biotech initiated with an Outperform at RBC Capital 03/13/23 Stifel Arcellx initiated with a Buy at Stifel 01/27/23 BTIG BTIG sees Legend commercializing Carvykti in earlier lines after study hits goal 01/27/23 Piper Sandler Piper keeps $78 target on Legend Biotech after Carvykti trial hits 03/03/23 Volkswagen reports FY22 revenue EUR279.2B, up 11.6% 02/07/23 Volkswagen reports preliminary FY adjusted operating profit EUR 22.5B 10/28/22 Volkswagen reports Q3 revenue EUR 70.7B vs. EUR 56.9B last year 03/09/23 Vital Farms sees FY23 revenue more than $450M, consensus $440.77M 03/09/23 Vital Farms sees FY23 revenue $450M +, consensus $440.77M. 03/09/23 Vital Farms reports Q4 EPS 4c, consensus 4c 03/09/23 Vital Farms reports Q4 EPS 4c, consensus 4c 01/31/23 UBS reports Q4 EPS 50c, profit before tax $1.9B 10/25/22 UBS reports Q3 EPS 52c, net profit $1.7B 03/02/23 TD Bank reports Q1 adjusted EPS C$2.23 vs. C$2.08 last year 12/01/22 Toronto-Dominion expects to meet/exceed adjusted EPS growth 7%-10% in 2023 12/01/22 Toronto-Dominion reports Q4 adjusted EPS C$2.18 vs. C$2.09 last year $61.90 / -10.735 (-14.78%)
02/23/23 Block reports Q4 EPS 22c, consensus 30c 11/03/22 Block reports Q3 adjusted EPS 42c, consensus 23c 11/03/22 Notable companies reporting after market close 02/15/23 RingCentral sees FY23 adjusted EPS $3.04-$3.10, consensus $2.84 02/15/23 RingCentral sees Q1 adjusted EPS 69c-70c, consensus 63c 02/15/23 RingCentral reports Q4 adjusted EPS 60c, consensus 59c 02/15/23 Notable companies reporting after market close $802.35 / +47.93 (+6.35%)
02/03/23 Regeneron reports Q4 adjusted EPS $12.56, consensus $10.03 02/02/23 Notable companies reporting before tomorrow's open 01/09/23 Regeneron sees about $1.5B in Q4 U.S. net product sales of Eylea 03/08/23 MDxHealth reports Q4 revenue $12.9M versus $6M last year 11/29/22 MDxHealth sees FY23 revenue $65M-$70M, consensus $67.03M 11/29/22 MDxHealth cuts FY22 revenue view to $36.5M-$37.5M from $40M-$42M 10/27/22 MDxHealth reports Q3 revenue $11.2M $154.30 / -8.525 (-5.24%)
03/23/23 Genuine Parts sees FY25 EPS $11-$11.50 03/23/23 Genuine Parts sees FY23 EPS $8.80-$8.95, consensus $8.92 02/23/23 Genuine Parts sees FY23 EPS $8.80-$8.95, consensus $8.73 02/23/23 Genuine Parts reports Q4 adjusted EPS $2.05, consensus $1.89 02/23/23 Farfetch sees FY23 adjusted EBITDA margin 1%-3% 02/23/23 Farfetch reports Q4 adjusted EPS (25c), consensus (47c) 02/23/23 Notable companies reporting after market close 11/17/22 Farfetch reports Q3 adjusted EPS (24c), consensus (28c) 01/18/23 First Horizon reports Q4 adjusted EPS 51c, consensus 48c 01/18/23 First Horizon reports Q4 adjusted EPS 51c, consensus 48c 10/18/22 First Horizon reports Q3 adjusted EPS 44c, consensus 43c 02/09/23 Credit Suisse reports Q4 net revenue CHF 3.06B vs. CHF 4.58B last year 10/27/22 Credit Suisse reports Q3 net revenue CHF 3.8B vs. CHF 5.43B last year 01/23/23 Crane sees FY23 EPS $3.40-$3.70 post separation 01/23/23 Crane reports Q4 EPS $2.13, consensus $1.90 10/24/22 Crane narrows FY22 EPS view to $7.58-$7.72 from $7.45-$7.85, consensus $7.75 10/24/22 Crane reports Q3 adjusted EPS $1.86, consensus $1.85 $66.28 / -10.96 (-14.19%)
02/21/23 Coinbase reports Q4 EPS ($2.46) vs. $3.32 y/y 02/21/23 Notable companies reporting after market close 01/10/23 Coinbase sees FY22 adjusted EBITDA within negative $500M loss 'guardrail' 12/07/22 Coinbase CEO tells Bloomberg 2022 revenue seen down 50% or more 02/28/23 Cracker Barrel sees FY23 total revenue growth 7%-9%, consensus $3.48B 02/28/23 Cracker Barrel reports Q2 adjusted EPS $1.48, consensus $1.36 12/02/22 Cracker Barrel narrows FY23 total revenue growth view to 6%-8% from 7%-8% 12/02/22 Cracker Barrel reports Q1 adjusted EPS 99c, consensus $1.22 12/28/22 Cal-Maine Foods reports Q2 EPS $4.07, consensus $4.24 09/27/22 Cal-Maine Foods reports Q1 EPS $2.57, consensus $2.56 03/01/23 Axonics backs FY23 revenue view of $342M, consensus $336.4M 03/01/23 Axonics reports Q4 EPS 1c, consensus (24c) 01/11/23 Axonics sees FY23 revenue $342M, consensus $327.2M 01/11/23 Axonics sees Q4 revenue $85.6M-$86.0M, consensus $74.3M
Recommendations
BMO Capital analyst Evan…
BMO Capital analyst Evan Seigerman raised the firm's price target on Regeneron to $1,040 from $1,025 and keeps an Outperform rating on the shares. The analyst is updating BMO's model to reflect the firm's confidence in Dupixent's commercial COPD opportunity, assigning 90% probability of success for the drug following validation BOREAS Phase 3 study readout and no competition in severe COPD. Regeneron's ability to translate R&D spend to enterprise value growth should not be underestimated, the firm tells investors in a research note.
Show Hide Related Items >> <<
$802.35 / +47.93 (+6.35%)
03/23/23 Regeneron, Sanofi report Dupixent trial meets primary and secondary endpoints 03/22/23 Regeneron announces FDA approval of Evkeeza for young children 03/21/23 Regeneron, Sanofi announce EC approval of Dupixent 03/19/23 Regeneron, Sanofi present results from Dupixent clinical trial $802.35 / +47.93 (+6.35%)
03/24/23 Wells Fargo Regeneron price target raised to $915 from $860 at Wells Fargo 03/24/23 Baird Regeneron price target raised to $800 from $756 at Baird 03/24/23 Barclays Regeneron price target raised to $915 from $815 at Barclays 03/24/23 Jefferies Regeneron upgraded to Buy on COPD opportunity at Jefferies $802.35 / +47.93 (+6.35%)
02/03/23 Regeneron reports Q4 adjusted EPS $12.56, consensus $10.03 02/02/23 Notable companies reporting before tomorrow's open 01/09/23 Regeneron sees about $1.5B in Q4 U.S. net product sales of Eylea $802.35 / +47.93 (+6.35%)
11/04/22 Supreme Court to hear Amgen appeal in Repatha patent dispute, Bloomberg says $802.35 / +47.93 (+6.35%)
03/23/23 What You Missed On Wall Street On Thursday 03/23/23 What You Missed On Wall Street This Morning 02/03/23 Fly Intel: Pre-market Movers 01/30/23 What You Missed On Wall Street On Monday $802.35 / +47.93 (+6.35%)
03/23/23 Early notable gainers among liquid option names on March 23rd
Recommendations
Wells Fargo analyst Mohit…
Wells Fargo analyst Mohit Bansal raised the firm's price target on Regeneron to $915 from $860 and keeps an Overweight rating on the shares. The firm thinks COPD could be a $3.5B incremental opportunity for Dupi as a 30% reduction in events and corroborating secondaries is a solid profile for first approved biologic in this indication, the analyst tells investors in a research note.
Show Hide Related Items >> <<
$802.35 / +47.93 (+6.35%)
03/23/23 Regeneron, Sanofi report Dupixent trial meets primary and secondary endpoints 03/22/23 Regeneron announces FDA approval of Evkeeza for young children 03/21/23 Regeneron, Sanofi announce EC approval of Dupixent 03/19/23 Regeneron, Sanofi present results from Dupixent clinical trial $802.35 / +47.93 (+6.35%)
03/24/23 Baird Regeneron price target raised to $800 from $756 at Baird 03/24/23 Barclays Regeneron price target raised to $915 from $815 at Barclays 03/24/23 Jefferies Regeneron upgraded to Buy on COPD opportunity at Jefferies 03/24/23 Jefferies Regeneron upgraded to Buy from Hold at Jefferies $802.35 / +47.93 (+6.35%)
02/03/23 Regeneron reports Q4 adjusted EPS $12.56, consensus $10.03 02/02/23 Notable companies reporting before tomorrow's open 01/09/23 Regeneron sees about $1.5B in Q4 U.S. net product sales of Eylea $802.35 / +47.93 (+6.35%)
11/04/22 Supreme Court to hear Amgen appeal in Repatha patent dispute, Bloomberg says $802.35 / +47.93 (+6.35%)
03/23/23 What You Missed On Wall Street On Thursday 03/23/23 What You Missed On Wall Street This Morning 02/03/23 Fly Intel: Pre-market Movers 01/30/23 What You Missed On Wall Street On Monday $802.35 / +47.93 (+6.35%)
03/23/23 Early notable gainers among liquid option names on March 23rd
Recommendations
Baird raised the…
Baird raised the firm's price target on Regeneron to $800 from $756 and keeps a Neutral rating on the shares. The analyst raised his target on impressive Dupixent results in COPD and also raised his sales estimates upward based on the data.
Show Hide Related Items >> <<
$802.35 / +47.93 (+6.35%)
03/23/23 Regeneron, Sanofi report Dupixent trial meets primary and secondary endpoints 03/22/23 Regeneron announces FDA approval of Evkeeza for young children 03/21/23 Regeneron, Sanofi announce EC approval of Dupixent 03/19/23 Regeneron, Sanofi present results from Dupixent clinical trial $802.35 / +47.93 (+6.35%)
03/24/23 Barclays Regeneron price target raised to $915 from $815 at Barclays 03/24/23 Jefferies Regeneron upgraded to Buy on COPD opportunity at Jefferies 03/24/23 Jefferies Regeneron upgraded to Buy from Hold at Jefferies 03/23/23 Raymond James Raymond James ups Regeneron to Market Perform as few downside catalysts remain $802.35 / +47.93 (+6.35%)
02/03/23 Regeneron reports Q4 adjusted EPS $12.56, consensus $10.03 02/02/23 Notable companies reporting before tomorrow's open 01/09/23 Regeneron sees about $1.5B in Q4 U.S. net product sales of Eylea $802.35 / +47.93 (+6.35%)
11/04/22 Supreme Court to hear Amgen appeal in Repatha patent dispute, Bloomberg says $802.35 / +47.93 (+6.35%)
03/23/23 What You Missed On Wall Street On Thursday 03/23/23 What You Missed On Wall Street This Morning 02/03/23 Fly Intel: Pre-market Movers 01/30/23 What You Missed On Wall Street On Monday $802.35 / +47.93 (+6.35%)
03/23/23 Early notable gainers among liquid option names on March 23rd
Recommendations
Barclays analyst Carter…
Barclays analyst Carter Gould raised the firm's price target on Regeneron Pharmaceuticals to $915 from $815 and keeps an Overweight rating on the shares. The analyst added chronic obstructive pulmonary disease to the model following yesterday's data, modeling 2030 sales in COPD of $4B and global sales across indications to $25B. Coupled with "underappreciated" operating margin expansion from the mid-to-high 50%s today, the firm sees Dupixent sales driving Sanofi collaboration revenues from $2.9B in 2022 to $10.7B in 2030. Barclays says Regeneron shares "can continue to work over the next 12 months."
Show Hide Related Items >> <<
$802.35 / +47.93 (+6.35%)
03/23/23 Regeneron, Sanofi report Dupixent trial meets primary and secondary endpoints 03/22/23 Regeneron announces FDA approval of Evkeeza for young children 03/21/23 Regeneron, Sanofi announce EC approval of Dupixent 03/19/23 Regeneron, Sanofi present results from Dupixent clinical trial $802.35 / +47.93 (+6.35%)
03/24/23 Jefferies Regeneron upgraded to Buy on COPD opportunity at Jefferies 03/24/23 Jefferies Regeneron upgraded to Buy from Hold at Jefferies 03/23/23 Raymond James Raymond James ups Regeneron to Market Perform as few downside catalysts remain 03/23/23 Raymond James Regeneron upgraded to Market Perform from Underperform at Raymond James $802.35 / +47.93 (+6.35%)
02/03/23 Regeneron reports Q4 adjusted EPS $12.56, consensus $10.03 02/02/23 Notable companies reporting before tomorrow's open 01/09/23 Regeneron sees about $1.5B in Q4 U.S. net product sales of Eylea $802.35 / +47.93 (+6.35%)
11/04/22 Supreme Court to hear Amgen appeal in Repatha patent dispute, Bloomberg says $802.35 / +47.93 (+6.35%)
03/23/23 What You Missed On Wall Street On Thursday 03/23/23 What You Missed On Wall Street This Morning 02/03/23 Fly Intel: Pre-market Movers 01/30/23 What You Missed On Wall Street On Monday $802.35 / +47.93 (+6.35%)
03/23/23 Early notable gainers among liquid option names on March 23rd
Upgrade
Jefferies analyst Akash…
Jefferies analyst Akash Tewari upgraded Regeneron Pharmaceuticals to Buy from Hold with a price target of $925, up from $675. Dupixent "well exceeded" the buy-side bar, showing a 30% reduction over placebo in patients with uncontrolled chronic obstructive pulmonary disease, the analyst tells investors in a research note. The firm thinks COPD could be a $4B opportunity for Dupixent and also increased Regeneron's IL-33 sales potential to $2Bn given the signal in non-smokers. Despite the macro environment, Regeneron "hit two home runs within a short period of time" with Eylea data and Dupixent in COPD, contends Jefferies.
Show Hide Related Items >> <<
$802.35 / +47.93 (+6.35%)
03/23/23 Regeneron, Sanofi report Dupixent trial meets primary and secondary endpoints 03/22/23 Regeneron announces FDA approval of Evkeeza for young children 03/21/23 Regeneron, Sanofi announce EC approval of Dupixent 03/19/23 Regeneron, Sanofi present results from Dupixent clinical trial $802.35 / +47.93 (+6.35%)
03/24/23 Jefferies Regeneron upgraded to Buy from Hold at Jefferies 03/23/23 Raymond James Raymond James ups Regeneron to Market Perform as few downside catalysts remain 03/23/23 Raymond James Regeneron upgraded to Market Perform from Underperform at Raymond James 03/20/23 RBC Capital Regeneron price target lowered to $802 from $806 at RBC Capital $802.35 / +47.93 (+6.35%)
02/03/23 Regeneron reports Q4 adjusted EPS $12.56, consensus $10.03 02/02/23 Notable companies reporting before tomorrow's open 01/09/23 Regeneron sees about $1.5B in Q4 U.S. net product sales of Eylea $802.35 / +47.93 (+6.35%)
11/04/22 Supreme Court to hear Amgen appeal in Repatha patent dispute, Bloomberg says $802.35 / +47.93 (+6.35%)
03/23/23 What You Missed On Wall Street On Thursday 03/23/23 What You Missed On Wall Street This Morning 02/03/23 Fly Intel: Pre-market Movers 01/30/23 What You Missed On Wall Street On Monday $802.35 / +47.93 (+6.35%)
03/23/23 Early notable gainers among liquid option names on March 23rd
Upgrade
Jefferies analyst Akash…
Jefferies analyst Akash Tewari upgraded Regeneron Pharmaceuticals to Buy from Hold with a price target of $925, up from $675.
Show Hide Related Items >> <<
$802.35 / +47.93 (+6.35%)
03/23/23 Regeneron, Sanofi report Dupixent trial meets primary and secondary endpoints 03/22/23 Regeneron announces FDA approval of Evkeeza for young children 03/21/23 Regeneron, Sanofi announce EC approval of Dupixent 03/19/23 Regeneron, Sanofi present results from Dupixent clinical trial $802.35 / +47.93 (+6.35%)
03/23/23 Raymond James Raymond James ups Regeneron to Market Perform as few downside catalysts remain 03/23/23 Raymond James Regeneron upgraded to Market Perform from Underperform at Raymond James 03/20/23 RBC Capital Regeneron price target lowered to $802 from $806 at RBC Capital 03/17/23 Morgan Stanley Regeneron pressure from CMS draft a buying opportunity, says Morgan Stanley $802.35 / +47.93 (+6.35%)
02/03/23 Regeneron reports Q4 adjusted EPS $12.56, consensus $10.03 02/02/23 Notable companies reporting before tomorrow's open 01/09/23 Regeneron sees about $1.5B in Q4 U.S. net product sales of Eylea $802.35 / +47.93 (+6.35%)
11/04/22 Supreme Court to hear Amgen appeal in Repatha patent dispute, Bloomberg says $802.35 / +47.93 (+6.35%)
03/23/23 What You Missed On Wall Street On Thursday 03/23/23 What You Missed On Wall Street This Morning 02/03/23 Fly Intel: Pre-market Movers 01/30/23 What You Missed On Wall Street On Monday $802.35 / +47.93 (+6.35%)
03/23/23 Early notable gainers among liquid option names on March 23rd
Thursday
On The Fly
Get caught up quickly on…
Show Hide Related Items >> <<
03/14/23 Senate Democrats urge Walmart, Kroger, others to sell mifepristone 03/02/23 Walmart to open 28 new Walmart Health center locations in 2024 02/28/23 Citi, Walmart introduce the Bridge built by Citi platform to Walmart suppliers 02/28/23 Walmart, CareSource enter agreement to address health disparities 03/23/23 Uranium Energy slides as Kerrisdale says short shares, calls miner 'radioactive' 01/25/23 Uranium Energy receives $17.85M from DOE 12/20/22 Uranium Energy awarded contract from U.S. DOE 10/12/22 Uranium Energy to acquire Rio Tinto Roughrider uranium development project 03/20/23 S&P revises UBS Group outlook to Negative, affirms ratings 03/20/23 UBS rises 7.9% 03/19/23 Credit Suisse says UBS confident staff employment will be continued 03/20/23 Moody's upgrades Tesla's credit rating, declares outlook stable 03/14/23 Cathie Wood's ARK Investment bought 2.6K shares of Tesla today 03/13/23 Cathie Wood's ARK Investment bought 26.7K shares of Tesla today $41.18 / -14.95 (-26.63%)
03/23/23 Trupanion announces CFO Wolff to step down, Li to serve as interim CFO 01/10/23 Trupanion announces proposal to eliminate staggered board 01/10/23 Trupanion CEO to assume additional role as chair of the board 11/10/22 Aflac, Trupanion announce joint venture in Japan $61.90 / -10.735 (-14.78%)
03/23/23 Block exploring legal action against Hindenburg after 'misleading' report 03/23/23 Block calls Hindenburg report 'factually inaccurate and misleading' 03/23/23 Block falls -13.2% 03/23/23 Block falls -19.4% 03/18/23 Sanofi says moderate-to-severe atopic hand, foot dermatitis trial met endpoints 03/23/23 Steelcase rises 14.1% 03/23/23 Steelcase rises 13.5% 03/22/23 Steelcase spikes 13% higher after reporting quarterly results and guidance 10/20/22 Steelcase appoints Gupta to board of directors 03/20/23 Starbucks announces Laxman Narasimhan assumes role of CEO 03/01/23 Senator Sanders announces HELP panel vote on Starbucks CEO subpoena 02/23/23 Starbucks introduces Starbucks Oleato coffee, olive oil beverages 02/20/23 PepsiCo recalling Starbucks vanilla Frappuccino bottles $802.35 / +47.93 (+6.35%)
03/23/23 Regeneron, Sanofi report Dupixent trial meets primary and secondary endpoints 03/22/23 Regeneron announces FDA approval of Evkeeza for young children 03/21/23 Regeneron, Sanofi announce EC approval of Dupixent 03/19/23 Regeneron, Sanofi present results from Dupixent clinical trial 03/23/23 On Holding rises 12.9% 03/21/23 On Holding rises 28.1% 03/21/23 On Holding rises 24.1% 03/21/23 On Holding rises 22.9% 03/22/23 KB Home sees Q2 average selling price of about $480K 03/22/23 KB Home sees Q2 housing revenue at $1.35B-$1.50B 03/22/23 KB Home says labor costs proving to be sticky 03/22/23 KB Home says encouraged with recent order trends 03/03/23 Samsara rises 21.2% 03/03/23 Samsara rises 13.3% 03/02/23 Samsara says Q1 will be lowest quarter of the year on net new ARR 12/02/22 Samsara rises 21.9% 01/11/23 ICL signs strategic partnership agreement with General Mills 12/05/22 IHOP and General Mills partner to turn the brand's iconic pancakes into cereal 11/14/22 General Mills director Cordani sells 26,100 common shares 10/03/22 General Mills exec sells $2.0M in common stock $392.67 / -23.28 (-5.60%)
03/23/23 FactSet expects to resume share repurchase program in Q3, Q4 01/26/23 BMO Wealth Management selects FactSet as market data provider 01/11/23 FactSet, Coin Metrics collaborate for digital asset data, analytics 12/20/22 FactSet not planning to resume buybacks until at least Q3 03/23/23 Ford backs FY23 adjusted EBIT view $9B-$11B 03/23/23 Ford to report financial results based on three new global business segments 03/21/23 Ford selects John Dion to be chief transformation officer 03/21/23 EU passenger car registrations up 11.5% in February 03/23/23 Darden reports Q3 blended same-restaurant sales increase of 11.7% 03/19/23 Fly Intel: Top five weekend stock stories 12/16/22 Darden reports Q2 blended same-restaurant sales increase of 7.3% $66.28 / -10.96 (-14.19%)
03/22/23 Coinbase says 'we are confident in the legality of our assets and services' 03/22/23 Coinbase falls 7% to $71.70 after announcing Wells Notice from SEC 03/22/23 Coinbase receives Wells Notice from SEC 03/21/23 Cathie Wood's ARK Investment sold 161K shares of Coinbase today 03/14/23 SPDR Regional Banking ETF KRE jumps 9% at the open 03/14/23 Comerica trading resumes 03/14/23 Comerica trading halted, volatility trading pause 03/13/23 Comerica trading resumes 03/23/23 Chewy falls -5.7% 03/22/23 Chewy says closing two oldest non-automated fulfillment centers 12/08/22 Chewy says now expects FY22 capex to come in slightly below 2.5% of sales 10/20/22 Chewy expands CarePlus with new plan by Lemonade Pet 12/05/22 BellRing Brands announces new $50M share repurchase plan 11/22/22 Post Holdings to exit ownership of BellRing Brands 03/23/23 Boeing, Japan Airlines finalize order for 21 737-8 jets 03/17/23 Boeing awarded $1.95B Army contract modification 03/14/23 Boeing reports 28 commercial airplane deliveries, 5 orders in February 03/14/23 Saudi Arabian Airlines selects up to 49 Boeing 787 Dreamliners $271.64 / +18.54 (+7.33%)
03/23/23 Accenture expected to cut 19,000 people, or 2.5% of current workforce 03/23/23 Accenture says initiated actions to streamline operations in Q2 03/23/23 Accenture reports Q2 new bookings $22.1B 03/23/23 Accenture declares quarterly dividend of $1.12 per share, up 15% y/y 02/16/23 Accolade announces Michael Hilton to join board of directors 02/06/23 Cathie Wood's ARK Investment bought 313.7K shares of Accolade today $66.28 / -10.96 (-14.19%)
03/24/23 Compass Point Coinbase Wells notice fight will take 'years to resolve,' says Compass Point 03/24/23 TD Cowen Coinbase downgraded to Underperform from Market Perform at TD Cowen 03/23/23 BofA SEC action to weigh on Coinbase shares, says BofA 03/23/23 Jefferies Coinbase Wells notice likely precursor to enforcement action, says Jefferies 03/21/23 Morgan Stanley EV price cuts 'not a fad, but a trend,' says Morgan Stanley 02/15/23 Tudor Pickering Ford downgraded to Hold from Buy at Tudor Pickering 02/14/23 Barclays Barclays starts autos and mobility sector, says Tesla stands out 02/14/23 Barclays Ford initiated with an Equal Weight at Barclays 03/24/23 BofA Darden price target raised to $172 from $170 at BofA 03/24/23 Credit Suisse Darden price target raised to $165 from $157 at Credit Suisse 03/24/23 Baird Darden price target raised to $152 from $148 at Baird 03/24/23 Citi Darden price target raised to $169 from $165 at Citi $61.90 / -10.735 (-14.78%)
03/24/23 Oppenheimer Oppenheimer remains on the sidelines for Block after short report 03/24/23 BofA Block shares 'overreacting' to short seller report, says BofA 03/24/23 Citi Block short seller response likely not enough, says Citi 03/24/23 Atlantic Equities Atlantic Equities downgrades Block pending more clarity on short report 03/20/23 Deutsche Bank General Mills price target lowered to $84 from $88 at Deutsche Bank 02/22/23 Stifel General Mills price target raised to $84 from $82 at Stifel 02/01/23 Stifel Stifel not surprised by potential competitive entrant from Blue Buffalo 02/01/23 Mizuho General Mills initiated with a Neutral at Mizuho 03/23/23 Guggenheim Accolade upgraded at Guggenheim after benefits survey, management meetings 03/23/23 Guggenheim Accolade upgraded to Buy from Neutral at Guggenheim 02/09/23 Jefferies Accolade downgraded to Hold at Jefferies after 'lukewarm' survey results 02/09/23 Jefferies Accolade downgraded to Hold from Buy at Jefferies 03/23/23 Evercore ISI Chewy price target lowered to $53 from $55 at Evercore ISI 03/23/23 Morgan Stanley PetMed Express price target lowered to $17 from $18 at Morgan Stanley 03/23/23 Deutsche Bank Chewy downgraded to Hold from Buy at Deutsche Bank 03/23/23 Barclays Chewy price target lowered to $33 from $35 at Barclays 03/23/23 Morgan Stanley Samsara downgraded to Equal Weight from Overweight at Morgan Stanley 03/16/23 Piper Sandler Piper starts Samsara at Neutral with valuation not compelling 03/15/23 Piper Sandler Samsara initiated with a Neutral at Piper Sandler 03/03/23 Goldman Sachs Samsara upgraded to Buy at Goldman ahead of free cash flow inflection 03/23/23 Truist Truist upgrades BellRing Brands to Buy with removed overhang of Post Holdings 03/23/23 Truist BellRing Brands upgraded to Buy from Hold at Truist 02/09/23 Bernstein Bernstein ponders takeover targets for J.M. Smucker after pet food sale 02/08/23 Morgan Stanley BellRing Brands price target raised to $32 from $30 at Morgan Stanley 03/17/23 Gordon Haskett Gordon Haskett downgrades Dollar General with 'more questions than answers' 03/17/23 Loop Capital Honest Company price target lowered to $2 from $3 at Loop Capital 03/16/23 DA Davidson BRC Inc. price target lowered to $10 from $12 at DA Davidson 03/07/23 Morgan Stanley Survey points to Walmart+ nearing 18.5M members, says Morgan Stanley 02/15/23 BMO Capital Starbucks price target raised to $125 from $120 at BMO Capital 02/06/23 Argus Starbucks facing weaker China comps, rising labor costs, says Argus 02/03/23 RBC Capital Starbucks price target lowered to $109 from $112 at RBC Capital 02/03/23 TD Cowen Starbucks price target raised to $116 from $112 at Cowen 03/22/23 Morgan Stanley Rivian now trading just below cash value, says Morgan Stanley 03/20/23 Morgan Stanley XPeng price target raised to $12.50 from $12 at Morgan Stanley 03/20/23 Morgan Stanley Li Auto price target raised to $30 from $23 at Morgan Stanley 03/24/23 Jefferies UBS downgraded to Hold from Buy at Jefferies 03/20/23 Barclays European Banks sector view downgraded to Neutral at Barclays 03/20/23 Societe Generale UBS downgraded to Hold from Buy at Societe Generale 03/20/23 Keefe Bruyette UBS downgraded to Underperform from Market Perform at Keefe Bruyette 03/23/23 Susquehanna Boeing orders from Japan sign of strong demand, says Susquehanna 03/23/23 Wolfe Research Boeing under $200 brings attractive entry point, says Wolfe Research 03/22/23 Wells Fargo Boeing price target lowered to $230 from $240 at Wells Fargo 03/16/23 Northcoast Boeing initiated with a Neutral at Northcoast $802.35 / +47.93 (+6.35%)
03/24/23 Wells Fargo Regeneron price target raised to $915 from $860 at Wells Fargo 03/24/23 Baird Regeneron price target raised to $800 from $756 at Baird 03/24/23 Barclays Regeneron price target raised to $915 from $815 at Barclays 03/24/23 Jefferies Regeneron upgraded to Buy on COPD opportunity at Jefferies 03/14/23 Jefferies Provention Bio downgraded to Hold from Buy at Jefferies 02/08/23 Morgan Stanley Regeneron named 'Catalyst Driven Idea' at Morgan Stanley ahead of COPD data 01/31/23 Berenberg Sanofi price target raised to EUR 100 from EUR 91 at Berenberg 12/21/22 Barclays Sanofi, Pfizer settled first California Zantac bellwether case, says Barclays 03/23/23 UBS On Holding price target raised to $39 from $27 at UBS 03/22/23 Baird On Holding price target raised to $33 from $31 at Baird 03/21/23 UBS On Holding Q4 results were 'exceptional', says UBS 03/21/23 Credit Suisse On Holding price target raised to $33 from $28 at Credit Suisse $41.18 / -14.95 (-26.63%)
03/24/23 Evercore ISI Trupanion price target lowered to $59 from $68 at Evercore ISI 03/15/23 BofA First BanCorp removed from 'Endeavor List' at BofA, four stocks added 02/16/23 Lake Street Trupanion price target raised to $75 from $67 at Lake Street 02/16/23 Canaccord Trupanion price target raised to $72 from $66 at Canaccord 10/19/22 H.C. Wainwright Uranium Energy price target raised to $8.25 from $7.25 at H.C. Wainwright 10/13/22 Canaccord Uranium Energy price target raised to $6.50 from $6.00 at Canaccord 06/15/22 Canaccord Uranium Energy price target raised to $6 from $5.50 at Canaccord 06/13/22 Canaccord Uranium Energy upgraded to Speculative Buy after deal at Canaccord 03/23/23 Truist Comerica price target lowered to $54 from $78 at Truist 03/16/23 Citi Citi refreshes North America Focus List with five changes 03/15/23 UBS Comerica initiated with a Buy at UBS 03/13/23 Odeon Capital Comerica downgraded to Hold from Buy at Odeon Capital $271.64 / +18.54 (+7.33%)
03/24/23 Susquehanna Accenture results landed above expectations, says Susquehanna 03/24/23 JPMorgan Accenture price target raised to $314 from $311 at JPMorgan 03/24/23 Wells Fargo Accenture price target raised to $294 from $289 at Wells Fargo 03/24/23 Citi Accenture price target raised to $310 from $300 at Citi 11/29/22 Benchmark Steelcase downgraded to Hold at Benchmark amid demand 'soft patch' 11/29/22 Benchmark Steelcase downgraded to Hold from Buy at Benchmark 10/04/22 Sidoti Steelcase upgraded to Buy from Neutral at Sidoti 09/23/22 Benchmark Steelcase price target lowered to $12 from $16 at Benchmark 03/24/23 Barclays KB Home price target raised to $51 from $42 at Barclays 03/24/23 JPMorgan KB Home upgraded to Neutral from Underweight at JPMorgan 03/23/23 RBC Capital KB Home price target raised to $37 from $34 at RBC Capital 03/23/23 UBS KB Home price target raised to $48 from $45 at UBS $392.67 / -23.28 (-5.60%)
03/24/23 Stifel FactSet price target lowered to $408 from $415 at Stifel 03/17/23 CICC FactSet initiated with an Outperform at CICC 01/12/23 Credit Suisse FactSet upgraded to Outperform from Neutral at Credit Suisse 12/21/22 Deutsche Bank FactSet price target lowered to $477 from $493 at Deutsche Bank 02/21/23 Walmart sees FY24 adjusted EPS $5.90-$6.05, consensus $6.50 02/21/23 Walmart sees Q1 adjusted EPS $1.25-$1.30, consensus $1.36 02/21/23 Walmart reports Q4 adjusted EPS $1.71, consensus $1.51 11/15/22 Walmart raises FY23 adjusted EPS view to down 5%-6% from down 9%-11% 01/31/23 UBS reports Q4 EPS 50c, profit before tax $1.9B 10/25/22 UBS reports Q3 EPS 52c, net profit $1.7B 03/02/23 Aehr Test Systems reiterates annual guidance, comments on Tesla statements 01/25/23 Tesla reports Q4 EPS $1.19, consensus $1.13 01/25/23 Notable companies reporting after market close 10/19/22 Tesla reports Q3 EPS $1.05, consensus 99c $41.18 / -14.95 (-26.63%)
02/16/23 Trupanion sees FY23 revenue $1.32B-$1.64B, consensus $1.31B 02/16/23 Trupanion sees Q1 revenue $249M-$253M, consensus $267.72M 02/15/23 Trupanion reports Q4 EPS (23c), consensus (29c) 11/03/22 Trupanion reports Q3 EPS (32c), consensus (28c) $61.90 / -10.735 (-14.78%)
02/23/23 Block reports Q4 EPS 22c, consensus 30c 02/23/23 Notable companies reporting after market close 11/03/22 Block reports Q3 adjusted EPS 42c, consensus 23c 11/03/22 Notable companies reporting after market close 02/03/23 Sanofi sees 2023 business EPS up at low single digit rate at CER 02/03/23 Sanofi reports Q4 business EPS EUR 1.71, up 17.4% at CER 10/28/22 Sanofi now sees 2022 business EPS growing 16% at CER 10/28/22 Sanofi reports Q3 business EPS EUR 2.88, up 17.9% at CER 03/22/23 Steelcase sees FY24 EPS 55c-75c, consensus 59c 03/22/23 Steelcase sees Q1 EPS (2c)-2c, consensus (7c) 03/22/23 Steelcase reports Q4 EPS 13c, consensus 11c 12/19/22 Steelcase sees Q4 adjusted EPS 11c-15c, consensus 12c 02/02/23 Starbucks reports Q1 EPS 75c, consensus 77c 11/03/22 Starbucks sees FY23 adjusted EPS growth at low end of 15%-20% range 11/03/22 Starbucks reports Q4 adjusted EPS 81c, consensus 72c $802.35 / +47.93 (+6.35%)
02/03/23 Regeneron reports Q4 adjusted EPS $12.56, consensus $10.03 02/02/23 Notable companies reporting before tomorrow's open 01/09/23 Regeneron sees about $1.5B in Q4 U.S. net product sales of Eylea 03/21/23 On Holding sees FY23 revenue of 'at least' CHF 1.7B vs. CHF 1.22B last year 03/21/23 On Holding reports Q4 EPS CHF0.02 vs. (CHF0.04) last year 11/16/22 On Holding raises FY22 revenue view to CHF 1.125B from CHF 1.1B 11/16/22 On Holding reports Q3 EPS CHF0.06 vs. CHF0.04 last year 03/22/23 KB Home reports Q1 EPS $1.45, consensus $1.14 01/11/23 KB Home reports Q4 EPS $2.47, consensus $2.87 03/02/23 Samsara sees FY24 EPS (7c) to (5c), consensus (15c) 03/02/23 Samsara sees Q1 EPS (6c) to (5c), consensus (5c) 03/02/23 Samsara reports Q4 EPS (2c), consensus (5c) 12/01/22 Samsara raises FY23 EPS view to (17c)-(16c) from (23c)-(21c), consensus (21c) 03/23/23 General Mills raises FY23 adjusted EPS view to up 8%-9% from up 7%-8% 03/23/23 General Mills reports Q3 adjusted EPS 97c, consensus 92c $392.67 / -23.28 (-5.60%)
03/23/23 FactSet sees 2023 adjusted EPS $14.50-$14.90, consensus $14.89 03/23/23 FactSet reports Q2 adjusted EPS $3.80, consensus $3.69 12/20/22 FactSet reaffirms 2023 adjusted EPS view $14.50-$14.90, consensus $14.79 12/20/22 FactSet reports Q1 adjusted EPS $3.99, consensus $3.61 02/02/23 Ford sees FY23 adjusted EBIT of $9B-$11B 02/02/23 Ford reports Q4 adjusted EPS 51c, consensus 62c 02/02/23 Notable companies reporting after market close 10/26/22 Ford reports Q3 adjusted EPS 39c, consensus 27c 03/23/23 Darden revises FY23 EPS view to $7.85-$8.00 from $7.60-$8.00, consensus $7.85 03/23/23 Darden reports Q3 EPS $2.34, consensus $2.25 03/22/23 Notable companies reporting before tomorrow's open $66.28 / -10.96 (-14.19%)
02/21/23 Coinbase reports Q4 EPS ($2.46) vs. $3.32 y/y 02/21/23 Notable companies reporting after market close 01/10/23 Coinbase sees FY22 adjusted EBITDA within negative $500M loss 'guardrail' 12/07/22 Coinbase CEO tells Bloomberg 2022 revenue seen down 50% or more 01/19/23 Comerica reports Q4 EPS $2.58, consensus $2.55 10/19/22 Comerica reports Q3 EPS $2.60, consensus $2.57 03/22/23 Chewy sees FY23 revenue $11.1B-$11.3B , consensus $11.13B 03/22/23 Chewy sees Q1 revenue $2.72B-$2.74B, consensus $2.67B 03/22/23 Chewy reports Q4 adjusted EPS 16c, consensus (11c) 03/22/23 Notable companies reporting after market close 02/06/23 BellRing Brands backs FY23 revenue view $1.56B-$1.64B, consensus $1.59B 02/06/23 BellRing Brands reports Q1 adjusted EPS 33c, consensus 27c 11/17/22 BellRing Brands sees FY23 revenue $1.56B-$1.64B, consensus $1.59B 11/17/22 BellRing Brands reports Q4 adjusted EPS 31c, consensus 29c 01/25/23 Boeing reports Q4 core EPS ($1.75), consensus 26c 01/24/23 Notable companies reporting before tomorrow's open 10/26/22 Boeing reports Q3 core EPS ($6.18), consensus 2c $271.64 / +18.54 (+7.33%)
03/23/23 Accenture sees Q3 revenue $16.1B-$16.7B, consensus $16.64B 03/23/23 Accenture raises FY23 EPS view to $11.41-$11.63 from $11.20-$11.52 03/23/23 Accenture reports Q2 adjusted EPS $2.69, consensus $2.50 12/16/22 Accenture sees Q2 revenue $15.2B-$15.75B, consensus $15.59B 01/09/23 Accolade guides initial FY24 revenue around $410M, consensus $405.4M 01/09/23 Accolade narrows FY23 revenue view to $361M-$365M, consensus $359.2M 01/09/23 Accolade sees Q4 revenue $97M-$101M, consensus $101.7M 01/09/23 Accolade reports Q3 EPS (56c), consensus (62c)
